StockData
Bone Biologics Corp logo

Bone Biologics Corp (BBLG) stock

BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 6/30
$0.29−0.02 (-5.92%)

Close on Nov 18, 2026Market cap $986.22KP/E –Yield –

Bone Biologics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Bone Biologics's enterprise value was -$3.40M on Nov 11, 2026, against -$3.36M a year earlier. Over the last 5 years it ranged from -$3.45M to $259.23M, with a median of $6.35M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$3.40M–
2025Dec 31, 2025-$3.45M-141.7%
2024Dec 31, 2024$8.26M+33.9%
2023Dec 29, 2023$6.17M-18.5%
2022Dec 30, 2022$7.57M-97.1%
2021Dec 31, 2021$259.23M-81.4%
2020Dec 31, 2020$1.39B+86.3%
2019Dec 31, 2019$747.44M-43.5%
2018Dec 31, 2018$1.32B–

More Bone Biologics figures

See a number that looks wrong?